Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Current Opinion in Molecular Therapeutics|March 2, 2006
Exosomes as novel therapeutic nanodevicesAlain Delcayre, Jean-Bernard Le PecqExpert Review of Anticancer Therapy|July 9, 2005
Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathwayAlain Delcayre, Helen Shu, Jean-Bernard Le PecqBlood Cells, Molecules & Diseases|July 19, 2005
Dexosomes as a therapeutic cancer vaccine: from bench to bedsideJean-Bernard Le PecqBlood Cells, Molecules & Diseases|August 10, 2005
Exosome Display technology: applications to the development of new diagnostics and therapeuticsAlain Delcayre, Angeles Estelles, Jeffrey Sperinde, et al.Cancer Research|February 19, 2008
Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responsesIngrid S Zeelenberg, Matias Ostrowski, Sophie Krumeich, et al.Biotechnology and Bioengineering|July 23, 2005
An analysis of variability in the manufacturing of dexosomes: implications for development of an autologous therapySanjay Patel, Anita Mehta-Damani, Helen Shu, et al.Journal of Translational Medicine|February 23, 2005
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancerMichael A Morse, Jennifer Garst, Takuya Osada, et al.Vaccine|October 18, 2011
Increasing vaccine potency through exosome antigen targetingZachary C Hartman, Junping Wei, Oliver K Glass, et al.Journal of Immunological Methods|October 16, 2002
Production and characterization of clinical grade exosomes derived from dendritic cellsHenry G Lamparski, Anita Metha-Damani, Jenq-Yuan Yao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptidesDi-Hwei Hsu, Pedro Paz, Gilbert Villaflor, et al.Pageof 3